National Peroxide Ltd

National Peroxide Ltd operates with a capital structure that includes a basic and diluted share count of 5.75 million shares, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, the company's liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in source documents. This lack of liquidity data limits the ability to evaluate short-term financial flexibility or debt obligations.

Profitability metrics for the company show a gross profit of INR 277.45 million and an operating income of INR 53.63 million, translating to a gross margin of 37.5% and an operating margin of 7.3%. These figures are below the industry median for Commodity Chemicals, which typically reports higher gross margins due to scale and pricing power. The net income of INR 50.84 million reflects a net margin of 6.9%, which is also below the industry median, suggesting potential inefficiencies in cost control or pricing strategy.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of segmental or geographic transparency increases the risk of overreliance on a single market or customer base, which could be vulnerable to regional economic shifts or supply chain disruptions.

Growth trajectory data is limited, as the outlook for the current and next fiscal years is not quantified in the available data. However, the company's revenue of INR 739.89 million in the latest period suggests a stable but modest scale of operations. Without disclosed revenue growth rates or capital expenditure plans, it is difficult to assess the company's long-term growth potential or investment in innovation.

Risk factors include the unassessed liquidity risk and the lack of detailed balance-sheet data, which could obscure potential debt obligations or working capital constraints. The dilution risk is currently low, as the basic and diluted share counts are identical, indicating no dilutive instruments are outstanding. However, the absence of a detailed capital structure analysis limits the ability to evaluate long-term financial stability.

Recent events and filings do not provide additional insight into the company's operations or strategic direction. The lack of recent transcripts or filings suggests limited public disclosure, which could be a concern for investors seeking transparency and governance assurance.